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ABSTRACT 
 
KAMINSKI, ANNE   The Expression in Yeast of the Metacaspase Scp3 from the Fungus 
Schizophyllum commune 
 
ADVISOR: Kristin M. Fox 
 
Metacaspases are caspase homologs that are found in plants, fungi, and protists. They are 
involved in programmed cell death, a structured and regulated process to break down cells. There 
is limited information available on metacaspases and further research is necessary to understand 
how they work. One reason metacaspases are studied is that they are considered to be a potential 
drug target for pathogenic microorganisms. Five metacaspases scp1-5 were identified in S. 
commune through their similarity to the yeast metacaspase Yca1. The overall goal of the lab is to 
study and characterize these proteins. This thesis outlines the path taken to express the 
Schizophyllum commune metacaspase scp3 in yeast. Previous efforts in our lab to express 
metacaspases in E. coli have not been successful. I hypothesized that yeast would be a more 
desirable expression vehicle due to its closer relationship to S. commune; a more similar 
environment could yield more active protein. Scp3 has been successfully cloned into a yeast 
expression vector pYES2.1/V5-His-TOPO® and β-galactosidase expression has been obtained in 
yeast with the expression control vector pYES1.2/V5-His/lacZ. Future work on this project will 
be to perform a point mutation in the expression plasmid to remove a stop codon before the scp3 
sequence.  
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Introduction 1   
INTRODUCTION 
 
Programmed Cell Death and Apoptosis 
  
 Programmed cell death (PCD) is a controlled process in which a cell dies by breaking 
itself down. It is distinguished from other types of cell death by the fact that it is highly regulated 
and structured. The most common form of PCD is apoptosis, a pathway that is initiated and 
coordinated by proteins known as caspases.1,2 When apoptosis is induced, the chromosomes start 
to condense, the nuclear envelope disintegrates, DNA fragments, and the plasma membrane 
bulges out. Eventually, the cell breaks into multiple membrane-enclosed sacs that are then 
engulfed by other cells.  
 Apoptosis occurs in many situations, including body patterning during development and 
during a response to stress. In addition, it is essential for the removal of damaged, aged, or 
superfluous cells.3 Stressors that induce apoptosis include osmotic pressure, oxidative stress, 
toxins, viruses, and aging.4 Apoptosis is initiated through either the extrinsic or the intrinsic 
pathway. The extrinsic pathway is initiated by outside signals from a neighboring cell that 
selected the other cell to undergo apoptosis. The intrinsic pathway occurs when the cell ceases to 
receive the constant external signals that normally suppress apoptosis.1 Problems with the 
apoptotic process may lead to diseases such as cancer and neurodegenerative disorders.5 
 Apoptosis is a conserved construct, having evolved from a process in ancient eukaryotic 
organisms. However, there are multiple hypotheses as to how PCD evolved starting in single-
celled organisms. One theory is that it was a way for a less healthy cell to sacrifice itself to 
benefit the colony, such as when there was a limited nutrient supply. On the other hand, there is 
no advantage for a single cell to undergo PCD; early death of an organism would not be selected 
for. It is therefore concluded that there must be other, non-PCD roles of the proteins that evolved 
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in the PCD pathway.2 As a result, caspases and metacaspases, the proteins responsible for PCD, 
hold other important roles in addition to programmed cell death, even in multicellular organisms. 
 
Caspases 
  
 Caspases are proteins classified as proteases, meaning they cleave other proteins. 
Caspases are significant because they are responsible for apoptosis in metazoans. They are also 
involved in many processes other than cell death, including inflammation, cell cycle control, cell 
proliferation and cell differentiation.4,6 Due to their multifunctionality, caspases have many 
targets consisting of transcription and elongation factors, ribosomal proteins, and structural 
molecules.4 In fact, a single caspase may have hundreds of different targets that it is able to 
discriminate.7 
 Directly after translation, caspases exist as inactive zymogens that must be cleaved in 
between the p20 and p10 subunits in order to be activated.8,9 p20 is a large catalytic domain on 
the N-terminal side of the protein, and p10 is a small domain on the C-terminus.9 The cleavage is 
either carried out autocatalytically by the caspase itself or performed by another caspase.8 The 
final structure is a catalytic dimer consisting of two of each subunit with two identical active 
sites.7 The active sites consist of a cysteine-histidine catalytic diad1,3,9 Once active, caspases 
cleave polypeptides, with specificity for cleaving after aspartic acid. This specificity is mainly a 
result of the S1 specificity pocket that contains two arginines and a glutamine, creating a spot of 
positive charge that complements the negatively charged aspartic acid.10
While caspases contain the same basic structures, they are grouped into effector or 
initiator caspases depending on their sequences and the order in which they are activated in 
PCD.8 Initiator caspases contain a large prodomain, a sequence on their N-terminus that codes 
for constituents such as the caspase recruitment domain (CARD) and the death effector domain 
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(DED) that are involved in protein-protein interactions responsible for guiding caspases into 
different cell death signaling pathways.8 However, prodomains are not necessarily required for 
caspase activity.5 The role of initiator caspases is to start the extrinsic and intrinsic pathways 
toward apoptosis.7 In addition, initiator caspases activate the effector caspases, which do not 
contain a significant prodomain, through cleavage.5,9 Both of the pathways converge with the 
activation of the effector caspases that perform most of the cleavages that result in the physical 
characteristics of apoptosis.7 
 Due to the fact that apoptosis, and therefore caspases, are involved in a variety of 
diseases, caspases are promising drug targets. Already it has been shown that caspase inhibitors 
are able to improve stroke and brain injury symptoms in animals.5 
 
Metacaspases 
  
 Metacaspases are caspase homologs that are found in plants, fungi, and protozoa; they are 
responsible for initiating PCD in these organisms.9,11 Two classes of caspase-like proteins, 
metacaspases and paracaspases, were first identified in 2000 by Uren et al. by the similarity of 
their sequences to caspases. Paracaspases, like caspases, are found in animals. On the other hand, 
metacaspases, the focus of our research, are found in plants, fungi, and protozoa, organisms that 
do not contain caspases. These three proteins share a common ancestor from early in the 
evolution of eukaryotes and are derivatives of ancient cysteine proteases.8 
 Metacaspases are sequence homologs to caspases and therefore have some structural 
similarities, such as the p20 and p10 subunits.12 Metacaspases are also split into two subsets, type 
I and type II. Type I metacaspases contain a prodomain that is similar to the CARD and DED 
domains of initiator caspases, whereas type II metacaspases do not contain a prodomain, like the 
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effector caspases.8 However, the distance between the p20 and p10 subunits in the Type II 
metacaspase is longer than that of the effector caspase by about 130 amino acids.9  
 Recently, another form of metacaspases was discovered in phytoplankton, Type III, 
where the p10 subunit lies on the N-terminus instead of the C-terminus. In addition to the Type 
III metacaspases, metacaspase-like proteases and Type I metacaspases lacking a prodomain were 
also found. This hints that the classification of metacaspases is more uncertain than previously 
thought.9 Depictions of the three types of metacaspases are shown in Figure 1. 
Figure 1. Diagram of the domains in type I, II, and III metacaspases. Type I metacaspases 
contain a prodomain on the N-terminus and Type III has p10 and p20 subunits in reverse order. 
Scp3, a Type II metacaspase, is indicated. 
 
 In addition to the subunits and prodomains, the cysteine-histidine active site of caspases 
is also conserved in metacaspases. However, the specificity of metacaspases is different: 
metacaspases cleave after lysine and arginine instead of aspartic acid.12 This is a significant 
difference because lysine and arginine are basic amino acids. The substrate specificity is 
determined by a binding site structure similar to the S1 pocket of caspases, indicating that the 
recognition mechanism for metacaspases and caspases is related.13 
While the activation mechanism of metacaspases is unknown, it is likely different than 
that of caspases. For instance, autocatalytic processing has been observed in metacaspases, but it 
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is not necessarily essential for activity. In fact, the crystal structures of some type I metacaspases 
show that they are monomers, not dimers like active caspases.9 The core hemoglobinase fold in 
metacaspases contains a β-sheet made up of eight strands, instead of the six in caspases. This 
structural difference prevents the dimerization of metacaspases. It also appears that metacaspases 
are regulated after translation in multiple ways, sometimes by other metacaspases.  
 Furthermore, metacaspase activity is highly dependent on cell conditions.4 For instance, 
the activity of some metacaspases is dependent on calcium, although excessive concentrations 
may cause a decrease in activity.14,15 In addition, higher temperatures increase autoprocessing, 
which, if uncontrolled, will ultimately lead to inactivation. Metacaspases also observe a pH 
dependency similar to that of caspases, with the enzyme most active when the catalytic cysteine 
is deprotonated.15 
 Metacaspases have been proven to be necessary for the induction of certain forms of PCD 
in various fungi, protozoa, and plants. However, the pathway of cell death and the exact role of 
metacaspases are still unclear.16 While metacaspases appear to be analogous to caspases in many 
ways, it is unknown if metacaspases act exactly as caspases in the apoptotic pathway.9 Since 
metacaspases are a relatively recent discovery, they are currently being studied to learn more 
about their structures, how they work, and the processes in which they are involved. The 
intention is that metacaspases will be able to be used as chemotherapy agents and as other drug 
targets. Metacaspases are medically relevant due to their involvement in cell death, as well as the 
fact that they are significantly different than caspases and are not found in humans.14  
 
Metacaspases and Non Cell Death Activity 
 
 It has already been established that caspases are involved in cell cycle progression, 
replication, cell movement, and cell differentiation in addition to apoptosis.6 The further 
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metacaspases are studied, the more information that is revealed indicating their multiple roles in 
plants, fungi and protozoa. Like caspases, metacaspases are known to be involved in cell cycle 
progression.11 Disrupting metacaspase expression, either by overexpression or deletion, results in 
stunted growth in Leishmania major. The cell cycle in yeast was also shown to be slowed with a 
deletion of its metacaspase Yca1.16 In addition, Yca1 is involved in proteostasis by breaking 
down proteins. Proteostasis is the balance of protein production with degradation and ensures 
that misfolded proteins are properly managed. Defects in this process result in insoluble protein 
aggregates, which are associated with Alzheimer’s, Huntington's, and Parkinson's Disease. Yca1 
is also possibly involved in ribosome biogenesis and protein synthesis.6 The role of metacaspases 
in apoptosis has already implicated them as a drug targets; the additional roles of metacaspases 
that are being discovered further increases the possibility of their usefulness in medicine.   
 
Schizophyllum commune 
  
 The metacaspases being studied by the Fox Lab come from the model organism 
Schizophyllum commune, a split gill mushroom that is used to study fungal genetics.17 S. 
commune genetics are studied for various reasons, including being the only mushroom-forming 
fungus that has had genes inactivated by homologous recombination. In addition, its recombinant 
DNA may be expressed in other fungi. S. commune is also relatively unique in that it is a 
mushroom that may be grown on artificial media. It also has a reasonably short life cycle of 10 
days and may be found on every continent except Antarctica. Professor Kristin Fox identified 
five metacaspases from S. commune, Scp1, Scp2, Scp3, Scp4, and Scp5. These proteins were 
determined to be metacaspases by a sequence alignment with yca1, the metacaspase from S. 
cerevisiae.18 The sequence alignment of Scp3 with Yca1 is shown in Figure 2.
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Figure 2. ClustalW2 alignment of the amino acid sequence for Yca1 and Scp3. The purple box 
designates the histidine and cysteine residues that form the active site. The asterisks indicate 
where the amino acids are the same, two dots show where they are very similar, one dot is 
somewhat similar. 
 
 The percent identity for Yca1 and Scp3 is 52%, meaning that they are homologous. The 
most significant similarity, shown with Scp3 in Figure 2, is that the S. commune metacaspases 
contain the conserved cysteine-histidine catalytic diad. One general difference between the two 
metacaspases is that Yca1 is almost 200 amino acids longer than scp3. In addition, Yca1 is a type 
I metacaspase, making it more similar to scp1, 2, 4, and 5 than scp3, which is Type II and has a 
truncated prodomain. Yca1 differs from the S. commune metacaspases in that it is the only 
metacaspase in S. cerevisiae. In addition, yeast is single-celled, whereas S. commune is 
multicellular.19 By studying the metacaspases in S. commune, we can determine if other fungal 
metacaspases share similar characteristics and roles with those of yeast.  
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Yeast as a Microorganism for Studying Proteins 
  
 The metacaspases we are studying come from S. commune, but we cannot access them 
directly because they exist in too small of a concentration to be easily isolated and studied. 
Therefore, we use microorganisms to produce the proteins of interest, typically resulting in much 
higher protein concentrations. 
 The yeast Saccharomyces cerevisiae is a microorganism commonly used for the 
expression of foreign proteins.20 S. cerevisiae contains a metacaspase of its own, yca1, but for 
this project, it is being used for its role as a classic model organism of eukaryotic systems.21 
While only single-celled, many characteristics of yeast remain conserved in higher eukaryotic 
organisms.20 While yeast is genetically more complex than bacteria, it still possesses some of the 
same attributes that make bacteria so useful and popular in biological research. Yeast is single-
celled, may be grown quickly in artificial media, and has a genome that is both small and entirely 
sequenced.20, 21,22 
 
My Project 
   
 The long-term goal of metacaspase research is to harness the roles of metacaspases in cell 
death and other fundamental processes for use in medicine. Currently, work persists to further 
characterize metacaspases, especially in reference to caspases. In addition, there is a lot left to 
learn about how metacaspases function and their part in the PCD pathway.  
 The overall goal of the Fox Lab is to express and characterize five metacaspases scp1, 
scp2, scp3, scp4, and scp5 from the fungus Schizophyllum commune. The most recent work has 
focused on the expression of scp3 in a soluble and active form.  
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 The metacaspase I am studying for my research is Scp3, which is type II and therefore 
has a very short prodomain. Previously, only Type I metacaspases have been found in fungi.16 
The short prodomain has resulted in more successful Scp3 expression; the other scp constructs 
we have worked with, 1, 2, and 5, could not be expressed without the prodomain deleted. The 
scp3 gene was successfully cloned into the vector pQE-80 and expressed in E. coli using IPTG 
by Dillon Bentancourt.23 Connor Gagliardi was also able to purify scp3 with a Ni2+ column, but 
he was unable to obtain significant evidence of proteolytic activity.18 The focus of Ethan Loew's 
'13 thesis was to express the p10 and p20 subunits independently, unfold them and refold them 
together into their final construct. The p20 subunit was successfully expressed, but work 
continues to express the p10 subunit.24 One part of Connor Gagliardi's research was the 
optimization of the expression of scp3 in E. coli, using both IPTG overexpression and 
autoinduction methods.18 The use of IPTG overexpression has been successful in producing large 
amounts of protein, but it existed in insoluble aggregates. Through autoinduction, more soluble 
protein has resulted, but in amounts too small to be useful for analysis.    
 The aim of my project is to use S. cerevisiae instead of E. coli as a vehicle for scp3 
production. The reasoning is that S. cerevisiae, a fungus, is physiologically more closely related 
to S. commune than is E. coli. Therefore, S. cerevisiae may yield a more appropriate environment 
for the metacaspases, allowing them to be expressed in a soluble and active form. In 
addition,Machado et al. have shown that the stability of a Trypanosoma brucei metacaspase 
decreased more at 37˚C, the growth temperature of E. coli, than at 30˚C, the growth temperature 
of yeast.15 Another possibility is that it may be possible to express the other metacaspases with 
their full prodomain, something that was not possible through E. coli expression. Being able to 
work with the full metacaspases would allow us to learn more about how the S. commune 
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metacaspases are structured and activated.  
 
Techniques 
 
PCR 
  
Polymerase chain reaction (PCR) is a method used to amplify a small segment of DNA. 
Double-stranded DNA that contains the target sequence is used as a template. First, the DNA is 
heated to 95˚C to separate the two strands. In the next step, the temperature is reduced to 50-
60˚C to allow for the primers to anneal to the DNA on either side of the target sequence. Primers 
are short pieces of single-stranded DNA that are designed to complement the target sequence and 
to direct the DNA polymerase so it only copies the desired sequence. Once the primers are 
annealed, the polymerase synthesizes two new strands that are complementary to the template 
DNA. As these three steps are repeated, the amount of the gene of interest increases 
exponentially. After 20 cycles, there will be more than a million copies of the target sequence.1 
 
Plasmids 
  
 A plasmid is a small circular piece of DNA that may be fabricated in a laboratory and 
inserted into bacterial or yeast cells. These plasmids are often small and easily replicated. 
Plasmids frequently contain traits such as antibiotic resistance to allow the identification of the 
cells that contain the plasmid. Antibiotic resistance is an example of a selectable marker.1 The 
plasmid used for my research is pYES2.1/V5-His-TOPO from the pYES2.1 TOPO® TA Yeast 
Expression Kit (Invitrogen). A diagram of the plasmid may be seen in Figure 3.  
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  Figure 3. Diagram of pYES2.1/V5-His-TOPO. The sites of ampicillin   
  resistance, URA3 gene, his tag, V5 epitope, and the point where scp3 is   
  ligated in. 
 
 pYES2.1/V5-His-TOPO can be inserted into both E. coli and yeast. To select for 
plasmid-containing E. coli, pYES confers resistance to ampicillin, an antibiotic. In order to select 
for yeast that contains the plasmid, pYES contains a URA3 gene. The URA3 gene is responsible 
for the production of uracil, an essential building block of DNA. The strain of yeast I am 
working with contains a deletion for this gene; therefore, it will only be able to grow in a uracil-
free medium if it contains the plasmid.
In addition to markers, plasmids often contain restriction sites that allow the plasmid to 
be cut, either for the insertion or the removal of a gene. Conversely, pYES2.1/V5-His-TOPO 
does not need to be cut first in order to insert a gene. Instead, it is linear, with an overhanging 
pYES2.1/V5-His-TOPO 
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thymine on each edge. Overhanging adenines are added to the edges of the PCR product. These 
adenines interact with the unpaired thymines in the plasmid, forming a complete, circular 
plasmid.  
 Other aspects of pYES2.1/V5-His-TOPO include an additional 6 histidines that add to the 
C terminus of the expressed protein. This tag of histidines may be used to purify the protein 
using a Ni2+ affinity column. In addition, a V5 epitope is added to the protein. The V5 epitope is 
recognized by a V5 antibody, which may be used as the primary antibody when performing a 
western blot, a method for detecting specific proteins.  
 Lastly, the kit also supplied an expression control plasmid, pYES2.1/V5-His/lacZ. This 
plasmid contains the gene for β-galactosidase, whose expression may be used to verify the 
methods used to transform the plasmid and express and detect the protein of interest. 
 
Transformation 
  
 The purpose of plasmids is to introduce foreign DNA into a microorganism. This is done 
through the process of transformation, which is the uptake of a plasmid by a cell. 
Transformations are often performed either through chemical treatment or by electroporation. 
The first step of a transformation is weakening the cell walls to permit the plasmid to enter the 
cell. In chemical transformation, the cells are heat shocked to induce transformation, and for 
electroporation, an electric current is used. Once the plasmid is inside the cell, the 
microorganism will create copies of the plasmid along with its own DNA as it replicates. In 
addition, the cells will be able to express the genes in the plasmid. Transformation is not an 
extremely efficient process, but even if only a few cells take up the plasmid, they will proliferate, 
resulting in millions of cells that contain the plasmid. The plasmid may then be harvested by
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separation from the other cell components and genomic DNA. A diagram of the transformation 
process of a vector containing scp3 into E. coli is shown in Figure 4.
 
 
Figure 4. Diagram showing the transformation of a plasmid into E. coli. 
 
 
Gel Electrophoresis 
 
Gel electrophoresis is used to separate and analyze proteins and DNA fragments based on 
size. Both of these methods use an electric current to pull the negatively charged molecules 
through a gel matrix. Smaller molecules are faster to travel through the gel and larger molecules 
are slower. Different concentrations of agarose are used depending on the size of the DNA 
fragments being separated. The gel is stained with ethidium bromide, which intercalates into the 
DNA and fluoresces under UV light. Each band on the gel represents a DNA fragment of a 
particular size. Proteins are analyzed through sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). The SDS denatures the proteins and surrounds them with negative 
charge so that the protein separation is only by size, not shape or charge. The gel is soaked in a 
stain that binds to the protein.1  
 
Western Blotting 
 
 Western blotting is a method used to detect one specific protein from an SDS-PAGE that 
contains many other proteins. First, the proteins from the SDS-PAGE gel are transferred to a 
membrane. In order to detect the protein of interest on the membrane, western blots require the 
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use of antibodies. Antibodies are molecules used by the immune system to identify foreign 
substances and may be generated in a laboratory to target specific proteins. The western blot 
membrane is bathed in an antibody that only binds the protein of interest. The membrane is then 
bathed in a second antibody that binds the first antibody. The secondary antibody contains a 
chemiluminescent compound that allows for the visualization of the protein. The result is a 
membrane with only one band where the protein of interest is, instead of the many bands that 
appear on an SDS-PAGE gel.1 
 
Protein Expression via GAL1 Promoter 
 
The expression plasmid pYES2.1/V5-His-TOPO contains a GAL1 promoter in front of 
the target protein sequence. In the presence of glucose, the native yeast protein Gal80 binds to 
the GAL1 activator, Gal40, repressing protein expression. When yeast is grown in the presence 
of galactose, Gal80 is no longer produced and the GAL1 is free, resulting in the expression of the 
target protein. 
 
The Fox Lab is studying metacaspases from S. commune in order to contribute to the 
current knowledge about the structure and function of metacaspases. Previous work to express 
metacaspases in E. coli has proven unsuccessful, so my goal was to find a solution to the 
expression problems faced previously. The purpose of my project was to use pYES to express 
Scp3 in yeast in order to obtain substantial amounts of functional protein. The techniques 
mentioned above were the foundation for my work to reach my goal of expressing Scp3 in yeast. 
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METHODS 
 
Protocols have been adapted from edition 2.7 of the Fox Lab Protocols (August 2013), the 
pYES2.1 TOPO® TA Expression Kit manual (April 2004), Current Protocols in Molecular 
Biology, and Current Genetics. Modified versions of these protocols, other methods, and recipes 
may be found in the Appendix.  
 
Amplification and Isolation of scp3 
 
Scp3 was amplified from the genomic DNA of S. commune. A set of primers was designed to 
enable TA cloning into the pYES2.1 TOPO® vector. 
 
Table 1. The primers used to amplify scp3, given in the 5' to 3' direction. The bolded nucleotides 
are padding to ensure in frame ligation. The other nucleotides are complementary to the template 
DNA. 
Upstream primer CAATGGAGTCGCATTGTAC 
Downstream primer   CCGTAGGCGCTTCAGCA 
 
The Qiagen Hotstar Taq DNA Polymerase kit was used for the scp3 amplification. Using the 
suggested protocol provided as a starting point, different PCR conditions including various 
annealing temperatures and the presence of Q solution were tested to optimize the amplification. 
The final protocol is shown in Table 2. 
Table 2. PCR amplification of scp3 setup. 
 µL/tube 
5x PCR buffer 10 
Upstream Primer 5 
Downstream Primer 5 
Sterile Barnstead Water 26.5 
Hotstar Taq Polymerase 1 
V109 cDNA 1:500 dilution 2.5 
 
A Biorad iCycler was used with the program "hostar1" saved under the user "annekaminski" 
with a hotstart at 95˚C. The samples were placed in row E to allow an annealing temperature of 
55˚C. The cycles and steps are shown in Table 3. 
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Table 3. PCR program "hotstar1" cycles. 
Cycle Repeats Steps Temperature (˚C) Time 
1 0  94 3 minutes 
  1 94 30 seconds 
2 35 2 50 1 minute 
  3 72 1 minute 
3 0  72 10 minutes 
4 0  18 ∞ 
 
 
The specific ingredients in the 5x PCR buffer and the Q solution may be found in the Qiagen 
Hotstar Taq DNA Polymerase kit manual. Immediately following the PCR reaction, A-tailing 
was performed with 0.2 µL Taq per reaction (Fox Lab Protocol 2-10). 
 
The PCR samples were electrophoresed on a 1% agarose gel and the band of spc3 was isolated 
from the gel. The amplified scp3 gene was then purified using the Qbiogene GENECLEAN 
Turbo kit (Fox Lab Protocols 3-1 and 3-2). 
 
Ligating scp3 into pYES2.1/V5-His-TOPO® 
 
The method of ligation was modified from the pYES2.1 TOPO® manual. 20µL of the geneclean 
product was combined with 1µL of the vector and 4µL salt solution provided with the kit. Other 
amounts of geneclean product may be used, but the salt concentration must stay at 1/6 of the 
ligation mixture. The reaction was incubated at room temperature for 5 minutes then set on ice 
and precipitated (Fox Lab Protocol 2-5). While this method was initially successful, it was 
unable to be reproduced. 
 
Transformation of Vector into DH5α   
 
The vector containing scp3 was transformed by electroporation into electrocompetent DH5α E. 
coli cells (prepared and frozen August 2012). The cells were plated on pre-warmed agar plates 
containing 50 µg/mL carbenicillin-Camp (Fox Lab Protocol 1-9). 
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Colony PCR 
A colony PCR was performed to test for the presence of scp3 in the transformed DH5α cells 
(Fox Lab Protocol 2-8). The primers indicated in Table 1 were used with the PCR program 
hotstar1 (Table 3). 80 colonies were tested, divided into 8 PCR reactions.  
 
Miniprep and Vector Analysis 
 
Several colonies were selected for further analysis. Cells from each colony were grown overnight 
at 37˚C in 5mL LB containing 50µg/mL CAMP. The cells were lysed and the plasmid DNA was 
separated from the genomic DNA of E. coli, using the Promega Wizard® Plus SV Minipreps 
DNA purification System (Fox Lab Protocol 2-1).  
 
The vectors were then digested with restriction enzymes Pst I and Sal I. The digest recipe is 
listed in Table 4. 
 
Table 4. Single tube recipe for the digest of pYES2.1/V5-His-TOPO® after scp3 ligation. 
 µL/tube 
Buffer D 2.0 
Acetylated BSA 0.2 
Sterile Barnstead Water 15.8 
PstI 0.5 
SalI 0.5 
Miniprep DNA 1.0 
 
 
The reaction was incubated at 37˚C overnight then electrophoresed on a 1% agarose gel (Fox 
Lab Protocols 2-3 and 3-1). Minipreps that were shown by the digest to have scp3 ligated in 
correctly were sent to the SUNY Center for Functional Genomics for sequencing (Fox Lab 
Protocols 2-9). 
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Transformation of pYES2.1/V5-His-TOPO® Into Yeast 
 
The yeast transformation protocol may be found in the Appendix. Both pYES containing scp3 
and the expression control vector with β-galactosidase were inserted into yeast. 1.5mL of an 
overnight culture of S. cerevisiae BY4741 in 10mL YPD medium were centrifuged in an 
Eppendorf tube and resuspended in 100µL One Step Buffer, recipe in Table 5. 
 
 
Table 5. One Step Buffer recipe. 
Solution Final concentration 
Lithium Acetate 0.2 M 
PEG 40% 
DTT 100 mM 
 
 
2µL of pYES miniprep DNA diluted 1:10, and 5.3µL of 10mg/mL salmon sperm DNA were 
added to the cells. This mixture was then vortexed and incubated in a 45˚C water bath for 30 
minutes. The cells were plated onto uracil dropout plates and incubated at 30˚C for three days. 
The recipe for uracil dropout media is listed in Table 6. 
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Table 6. Recipe for uracil dropout media. 
Reagent Percent of medium Concentration of 
Stock Solution 
Yeast Nitrogenous Base 
(with ammonium sulfate, 
no amino acids) 
0.67 N/A 
Glucose 2 20% 
Adenine 0.01 50x 
Arginine 0.01 100x 
Cysteine 0.01 N/A 
Leucine 0.01 50x 
Threonine 0.01 100x 
Tryptophan 0.01 50x 
Aspartic Acid 0.005 50x 
Histidine 0.005 100x 
Isoleucine 0.005 100x 
Methionine 0.005 100x 
Phenylalanine 0.005 100x 
Proline 0.005 100x 
Serine 0.005 100x 
Tyrosine 0.005 N/A 
Valine 0.005 100x 
 
The medium was prepared using 100x or 50x stock solutions of the reagents except yeast 
nitrogenous base, cysteine, and tyrosine, which were added as solids. The glucose was 
autoclaved separately as a 20% solution. For plates, agar was added at a concentration of 2% 
after the other reagents were dissolved. 
 
Expression of β-galactosidase 
 
Two colonies of transformed yeast were first cultured separately in 10mL of a primary culture, 
20% glucose uracil dropout medium. The cultures were incubated for two days in 50mL 
Erlenmeyer flasks at 30˚C, with shaking at 250-300 rpm. It was necessary for the 50mL 
induction culture to begin growth with an OD600 of 0.4. Therefore, the OD600 of the primary 
culture was used to calculate the volume of culture to add to the induction medium. A sample 
calculation is demonstrated in the Appendix. The determined amount of primary culture was 
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centrifuged so that the glucose medium could be removed. The cells were then resuspended in 
2mL of the 20% galactose induction medium, which was then transferred to 50mL of the 
induction medium in 250mL Erlenmyer flask. The induction medium consisted of uracil dropout 
medium with 20% galactose instead of glucose. The culture was grown at 30˚C for 24 hours, 
with 5mL samples of culture taken at various time points ranging from 0 to 30 hours. The 
samples were pelleted and stored at -80˚C. 
 
Yeast Lysis  
 
The frozen cell pellets were resuspended in breaking buffer (Table 7). 
 
Table 7. Yeast breaking buffer recipe. 
EDTA 1 mM 
Glycerol 5% 
PMSF 1 mM 
Sodium Phosphate, pH 
7.4 
50 mM 
 
The cells were then vortexed with 0.3 g glass beads for 30 seconds, then set on ice for 30 
seconds. This was repeated four times. The cells were then centrifuged and the lysate was 
removed. 
 
SDS-PAGE and Western Blot 
 
The yeast lysate was electrophoresed on a 12% acrylamide gel (Fox Lab Protocol 3-3). This gel 
was then used to perform a western blot (Fox Lab protocol 3-4). The primary antibody was 
mouse anti-V5 (Novex 1408864) and the secondary antibody was goat anti-mouse (Invitrogen 
626520). 
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RESULTS AND DISCUSSION 
 
Amplification of scp3 
 
Scp3 was amplified from S. commune V109 cDNA using PCR. The PCR was performed with 
Hotstar Taq, at annealing temperatures of 50˚C (without Q solution), 55˚C, and 60˚C (with Q 
solution).* The PCR was analyzed using a 1% agarose gel and the results are shown in Figure 5.  
Figure 5. 1% agarose gel showing amplification of scp3. Lane 1 is the 1kb molecular weight 
marker. The PCR reaction in lane 2 did not contain Q solution and had an annealing temperature 
of 50˚C. PCR reactions in lanes 3 and 4 contained 19µL Q solution and were performed with 
annealing temperatures of 55 and 60˚C respectively. The control PCR with no primers is in lane 
5 and the control with no template is in lane 6. Amplified scp3 is shown at 711 bp, indicated with 
an arrow. Lane 1 is a 1kb ladder 
 
The bands at 711 bp are amplified scp3, denoted with the arrow. The bands at the top of the gel 
in lanes 2 through 5 are the template DNA and the bands in lanes 2,3,4, and 6 are the primers. 
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From this gel, it was determined that the best PCR method was an annealing temperature of 50˚C 
with a reaction without Q solution (Figure 5, lane 2) since the scp3 band was the brightest. 
 
Ligation of scp3 into pYES and transformation into E. coli 
 
The amplified scp3 gene was successfully ligated into pYES through TA cloning. The ligation 
resulted in many colonies containing scp3, as shown by the colony PCR in Figure 6. 
Figure 6. 1% agarose gel of the colony PCR showing scp3 present in every reaction. Lane 1 
isthe 1Kb molecular weight marker and lane 10 is the blank PCR reaction with no template 
DNA. 
Scp3 was amplified in all of the PCR reactions, including a small amount in the blank. Mini 
preps were performed on the ten colonies in colony PCR 2 (lane 3) in order to obtain the plasmid 
DNA from the colonies. Restriction digests with PstI and SalI were used to verify the presence of 
scp3 and to determine if scp3 was ligated into pYES forwards or backwards. The possible 
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outcomes of the digest are illustrated in Figure 7. 
 
 
Figure 7. Illustrations showing the cleavage points of Sal I (red) and PstI (blue). Not drawn to 
scale. A) Scp3 ligated normally. Yields 3 fragments: 3,465, 2,643, and 488 bp. B) Scp3 ligated 
backwards. Yields 3 fragments: 3,554, 2,554, and 488 bp. C) No scp3 insert. Yields 2 fragments: 
488 and 5,398 bp. 
 
The digests were analyzed using 1% agarose gel electrophoresis, shown in Figure 8. 
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Figure 8. 1% agarose gel showing the restriction digest with PstI and SalI of pYES. Lane 1 is the 
1kb molecular weight marker and lane 2 is an undigested mini prep sample. Scp3 is shown 
ligated forwards in lanes 4, 5, 6, 8, 9, and 10; it is ligated backwards in lanes 3 and 7.  
 
The results of the digest with SalI and PstI showed that scp3 was present in all of the vectors and 
ligated properly in the plasmids analyzed in lanes 4, 5, 6, 8, 9, and 10. 
 
 
Verification of the scp3 sequence 
 
  
Once it was determined that scp3 was ligated into pYES, the vector was sequenced at the SUNY 
CFG Molecular Core Facility. The sequence of scp3 ligated into pYES matched the sequence of 
scp3 perfectly, shown by the sequence comparison in Figure 9.
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Figure 9. Nucleotide sequence of scp3 (Query) compared with the sequence in pYES (Sbjct) 
using Clustal W.26 
 
While there were no errors in the scp3 sequence, it was determined that there was a stop codon 
(TGA) in front of the start codon (ATG) of scp3.  This error was introduced through the primers. 
The beginning sequence including the stop and start codons is shown in Figure 10.
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Figure 10. The beginning sequence of scp3 in pYES showing the stop codon in front the start 
codon (boxed in red).  
 
 
Transformation into yeast and expression 
pYES2.1/V5-His/lacZ, the expression control plasmid containing β-galactosidase, was 
transformed into yeast and β-galactosidase was expressed using a galactose medium. The 
western blot in Figure 11 shows the expression of β-galactosidase from the kit-supplied 
expression control vector.  
 
Figure 11. Western blot of the expression of β-galactosidase in yeast using the expression 
control vector. The V5 antibody was used for detection. 
 
Stop Start 
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β-galactosidase expression was monitored for 30 hours, with strong expression occurring after at 
least 12 hours. The expression of β-galactosiadase shows that the methods developed to insert a 
plasmid into yeast and express the target protein were successful. This indicates that the inability 
to obtain Scp3 expression may be due to the mutation in the plasmid, not in the expression 
procedures that were being used. 
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CONCLUSIONS AND FUTURE WORK 
 
In order to remove the stop codon, mega primer site-directed mutagenesis was attempted. 
The goal was to mutate the G in the stop codon (TGA) to a C, creating a serine (TCA). This 
method was unsuccessful; I was unable to ligate the mutated scp3 into the vector. Instead, the 
ends of the cut vector ligated together. Future work will be to use an alternative method of 
mutagenesis using  the Q-5® Site-Directed Mutagenesis Kit (New England Biolabs, Inc.). Similar 
to mega primer mutagenesis, this method utilizes PCR. One primer contains a base-pair 
mismatch allowing the change from G to C in the sense strand of the plasmid to be perpetuated 
as the DNA is amplified. The primers sit back to back on the plasmid so that during the PCR, the 
entire plasmid is replicated. The ends of the plasmid are then ligated while DpnI digests the 
template DNA. 
While Scp3 has not yet been expressed in yeast, we are very close. I have developed a 
method for successfully expressing protein in yeast. The next step will be to remove the stop 
codon from the plasmid and then test the expression of Scp3.  
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APPENDIX 
 
YPD: Yeast Extract Peptone Dextrose Media 
1% Yeast Extract 
2% Peptone 
2% Dextrose (D-glucose) 
To make 1 L: 
1. Dissolve 10 g yeast extract, 10 g peptone, and 20 g dextrose in 1000 mL DI water.  
2. Autoclave on liquid cycle 
3. For liquid medium, store at room temperature or in 4˚C refrigerator.  
 
If making plates,  
Add 20 g agar and only add 900 mL of DI water to the YPD mixture before autoclaving. Do not 
add dextrose. Instead, prepare a 20% stock solution of dextrose and autoclave or filter sterilize 
separately. After autoclaving the YPD broth, add 100 mL of the 20% dextrose. (This is because 
autoclaving agar and dextrose together will cause the dextrose to carmelize) Let cool before 
pouring the plates.   
 
 
Uracil Dropout Media 
0.67% yeast nitrogen base (without amino acids and with ammonium sulfate) 
2% carbon source (i.e. glucose or raffinose)  
0.01% (adenine, arginine, cysteine, leucine, lysine, threonine, tryptophan, uracil)  
0.005% (aspartic acid, histidine, isoleucine, methionine, phenylalanine, proline, serine, tyrosine, 
valine)  
2% agar (for plates)  
 
Make 100X solutions of arginine, lysine, threonine, histidine, isoleucine, methionine, 
phenylalanine, serine, valine, and proline.  
Make 50X solutions of adenine, leucine, tryptophan, and aspartic acid.  
Add tyrosine and cysteine last, as solids. 
 
To make 1 L, add 10 mL of the 100X solutions, and 20 mL of the 50X solutions. Dissolve the 
yeast nitrogenous base and tyrosine and cysteine, bring to 900 mL. Add the agar last if making 
plates.  
 
**The stock amino acid solutions may be stored at RT 
**To make the induction/expression medium, use galactose instead of glucose 
 
Preparation of Sheared Salmon Sperm DNA 
Protocol from Current Protocols in Molecular Biology 
1. Dissolve 10 mg (0.01 g) salmon sperm DNA salt in 1 mL sterile Barnstead water by vortexing.  
(This is difficult to do because the consistency is like cotton. Had to wear gloves and tear with 
fingers) 
2. Shear with a 17-gauge needle (we may only have a 22-gauge)
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3. Place in boiling water bath for 10 minutes, then chill. 
4. Aliquot into multiple sterile 1.5 mL microfuge tubes and freeze at -20˚C. 
5. Warm before pipetting. 
 
1 Step Buffer for Yeast Transformation 
Protocol from “One step transformation of yeast” for Current Genetics 1992 
0.2 M Lithium Acetate 
40% PEG 
100 mM DTT 
Sterile Barnstead water 
 
Can make a 1 M stock solution of Lithium Acetate, a 50-70% PEG stock solution, and a 1 M 
DTT stock solution.  
 
To make 5 mL: 
1 mL of 1 M LiAc  
2.86 mL 70% PEG 
500 µL 1 M DTT 
640 µL sterile Barnstead water 
 
10X LiAc (1M Lithium Acetate), pH 7.5  
1. For 100 ml, dissolve 10.2 g of lithium acetate in 90 ml of deionized water.  
2. Adjust pH to 7.5 with dilute glacial acetic acid and bring up the volume to 100 ml.  
3. Filter sterilize and store at room temperature.  
 
Breaking Buffer 
50 mM sodium phosphate, pH 7.4 
1 mM EDTA (omit EDTA if using this buffer for purification on metal-chelating resins)  
5% glycerol  
1 mM PMSF  
 
0.1 M Sodium Phosphate, pH 7.4  
Sodium phosphate, monobasic (NaH2PO4·H2O; Sigma-Aldrich S9638)  
Sodium phosphate, dibasic (Na2HPO4·7H2O; Sigma-Aldrich S9390)  
 
1. Prepare 100 ml of 1 M NaH2PO4·H2O by dissolving 13.8 g in 90 ml of deionized water. 
Bring volume up to 100 ml. Filter-sterilize.  
2. Prepare 100 ml of 1 M Na2HPO4·7H2O by dissolving 26.81 g in 90 ml of deionized water. 
Bring volume up to 100 ml. Filter-sterilize.  
3. For 1L of 0.1 M sodium phosphate, pH 7.4, mix together 22.6 ml of 1 M NaH2PO4 and 77.4 
ml of 1 M Na2HPO4. Bring up the volume to 1 L with deionized water.  
4. Filter-sterilize and store at room temperature. 
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Yeast Transformation 
“One Step Transformation of Yeast” from Current Genetics, 1992 
 
1. Prepare an overnight liquid culture of yeast in 10 mLYPD in a 50 mL sterile conical tube, 
shaking at 30˚C. 
2. Fill 1-3 sterile 1.5 mL centrifuge tubes with the liquid culture using a sterile transfer pipette. 
3. Spin for 2 minutes at maximum speed. 
4. Remove supernatant and resuspend in  in 100 µL 1 Step Buffer 
5. Add 300-900 ng of plasmid DNA (may experiment with other amounts), plus a blank using 
sterile Barnstead water instead of DNA 
6. Add 5.3 µL salmon sperm DNA (10 mg/µL) 
7. Vortex and incubate in a 45˚C water bath for 30 minutes.  
8. Plate 100 µL on a uracil dropout agar plate, incubating at 30˚C for 3-4 days 
 
 
 
4-6 Protein Expression in Yeast with pYES 
pYES2.1 TOPO® TA Expression Kit, Invitrogen, 2004 
 
1. Prepare two 10 mL liquid cultures with glucose uracil dropout medium in sterilized 50 mL 
Erlenmeyer flasks covered in foil. Shake at 250 rpm in a 30˚C shaker for about 36-40 hours. 
2. Determine the OD600 of the culture and calculate the amount needed to create an OD600 of 0.4 
when diluted in 50 mL of induction medium 
 
 
Example:  
 
 
 
3. Remove the amount of culture determined in step 2 and centrifuge the cells at 1500 x g or 4.4 
x 1000 rpm for 5 minutes at 4˚C and remove the supernatant. 
4. Gently resuspend the pellet in 1-2 mL of induction medium (galactose uracil dropout)  
5. Add resuspension to 50 mL induction media in a 500 mL Erlenmeyer flask, shaking at 250 
rpm in 30˚C. 
6. Take samples ranging from 0 to 30 hours after inoculation into the induction media. 
7. At each time point, determine the OD600. Remove 5 mL of culture and centrifuge at max 
speed for 5 minutes at 4˚C.  
8. Remove the supernatant and resuspend the cells in 500 µL of sterile Barnstead water. 
9. Transfer the cells to a sterile 1.5 mL centrifuge tube and centrifuge for 30 seconds. Remove 
the supernatant and store at -80˚C.
€ 
(0.4OD /mL)(50mL)
3OD /mL = 6.67mL
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Preparing Yeast Lysates 
1. Resuspend pellets in 500 µL breaking buffer. Spin at 1500 x g for 5 minutes at 4˚C. Remove 
the supernatant.  
2. Resuspend the cells in a volume of breaking buffer to obtain an OD600 of 50-100 (determined 
earlier) 
3. Add about 0.2 g glass beads. Vortex for 30 seconds followed by 30 seconds on ice. Repeat 
four times. 
4. Centrifuge the samples for 10 minutes at maximum speed. 
5. Remove the supernatant and put it in a sterile microfuge tube. 
6. Determine the protein concentration in the lysate using BSA as a standard. 
7. Add SDS-PAGE sample buffer to a final concentration of 1X 
8. Load 20 µg of lysate onto SDS-PAGE gel. Then do western blot. 
**Amount of protein loaded on gel not 100% certain. 20 µg may be too much for the control. 
Do not need to determine protein concentration every single time, just until you have a good 
idea of how much protein to expect 
 
**V5 epitope and His tag add about 5kDa to the protein 
 
 
